Vanoxerine dihydrochloride (BioDeep_00000794459)

   


代谢物信息卡片


Vanoxerine dihydrochloride

化学式: C28H34Cl2F2N2O (522.2016)
中文名称: 伐诺司林二盐酸盐
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: C1CN(CCN1CCCC2=CC=CC=C2)CCOC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F.Cl.Cl
InChI: 2*1H

描述信息

D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents
D049990 - Membrane Transport Modulators

同义名列表

1 个代谢物同义名

Vanoxerine dihydrochloride



数据库引用编号

4 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。

亚细胞结构定位 关联基因列表


文献列表

  • Magdalena Górny, Agnieszka Wnuk, Adrianna Kamińska, Kinga Kamińska, Grażyna Chwatko, Anna Bilska-Wilkosz, Małgorzata Iciek, Małgorzata Kajta, Zofia Rogóż, Elżbieta Lorenc-Koci. Glutathione Deficiency and Alterations in the Sulfur Amino Acid Homeostasis during Early Postnatal Development as Potential Triggering Factors for Schizophrenia-Like Behavior in Adult Rats. Molecules (Basel, Switzerland). 2019 Nov; 24(23):. doi: 10.3390/molecules24234253. [PMID: 31766654]
  • Juliana R Bastos, Katherinne M Perico, Érica L Marciano Vieira, Antônio L Teixeira, Fabiana S Machado, Aline S de Miranda, Fabrício A Moreira. Inhibition of the dopamine transporter as an animal model of bipolar disorder mania: Locomotor response, neuroimmunological profile and pharmacological modulation. Journal of psychiatric research. 2018 07; 102(?):142-149. doi: 10.1016/j.jpsychires.2018.04.004. [PMID: 29656188]
  • Nadia Giordano, Attilio Iemolo, Maria Mancini, Fabrizio Cacace, Maria De Risi, Emanuele Claudio Latagliata, Veronica Ghiglieri, Gian Carlo Bellenchi, Stefano Puglisi-Allegra, Paolo Calabresi, Barbara Picconi, Elvira De Leonibus. Motor learning and metaplasticity in striatal neurons: relevance for Parkinson's disease. Brain : a journal of neurology. 2018 02; 141(2):505-520. doi: 10.1093/brain/awx351. [PMID: 29281030]
  • Egle Janenaite, Valentina Vengeliene, Anton Bespalov, Berthold Behl. Potential role of tyrosine hydroxylase in the loss of psychostimulant effect of amphetamine under conditions of impaired dopamine transporter activity. Behavioural brain research. 2017 09; 334(?):105-108. doi: 10.1016/j.bbr.2017.07.028. [PMID: 28750831]
  • C E Terrillion, D T Dao, R Cachope, M K Lobo, A C Puche, J F Cheer, T D Gould. Reduced levels of Cacna1c attenuate mesolimbic dopamine system function. Genes, brain, and behavior. 2017 06; 16(5):495-505. doi: 10.1111/gbb.12371. [PMID: 28186690]
  • Aviad Hai, Lili X Cai, Taekwan Lee, Victor S Lelyveld, Alan Jasanoff. Molecular fMRI of Serotonin Transport. Neuron. 2016 Nov; 92(4):754-765. doi: 10.1016/j.neuron.2016.09.048. [PMID: 27773583]
  • Sarah E Bradshaw, Kara L Agster, Barry D Waterhouse, Jill A McGaughy. Age-related changes in prefrontal norepinephrine transporter density: The basis for improved cognitive flexibility after low doses of atomoxetine in adolescent rats. Brain research. 2016 Jun; 1641(Pt B):245-57. doi: 10.1016/j.brainres.2016.01.001. [PMID: 26774596]
  • Manuela Meireles, Eduardo Moura, Maria Augusta Vieira-Coelho, Celestino Santos-Buelga, Susana Gonzalez-Manzano, Montserrat Dueñas, Nuno Mateus, Ana Faria, Conceição Calhau. Flavonoids as dopaminergic neuromodulators. Molecular nutrition & food research. 2016 Mar; 60(3):495-501. doi: 10.1002/mnfr.201500557. [PMID: 26582321]
  • Andrew M Novick, Gina L Forster, James E Hassell, Daniel R Davies, Jamie L Scholl, Kenneth J Renner, Michael J Watt. Increased dopamine transporter function as a mechanism for dopamine hypoactivity in the adult infralimbic medial prefrontal cortex following adolescent social stress. Neuropharmacology. 2015 Oct; 97(?):194-200. doi: 10.1016/j.neuropharm.2015.05.032. [PMID: 26056032]
  • Ana Isabelle G Queiroz, Maíra Moraes de Araújo, Tatiane da Silva Araújo, Greicy Coelho de Souza, Lígia Menezes Cavalcante, Michel de Jesus Souza Machado, David Freitas de Lucena, João Quevedo, Danielle Macêdo. GBR 12909 administration as an animal model of bipolar mania: time course of behavioral, brain oxidative alterations and effect of mood stabilizing drugs. Metabolic brain disease. 2015 Oct; 30(5):1207-15. doi: 10.1007/s11011-015-9697-6. [PMID: 26073232]
  • Christopher W Atcherley, Nicholas D Laude, Eric B Monroe, Kevin M Wood, Parastoo Hashemi, Michael L Heien. Improved Calibration of Voltammetric Sensors for Studying Pharmacological Effects on Dopamine Transporter Kinetics in Vivo. ACS chemical neuroscience. 2015 Sep; 6(9):1509-16. doi: 10.1021/cn500020s. [PMID: 25062330]
  • Narasimha M Midde, Yaxia Yuan, Pamela M Quizon, Wei-Lun Sun, Xiaoqin Huang, Chang-Guo Zhan, Jun Zhu. Mutations at tyrosine 88, lysine 92 and tyrosine 470 of human dopamine transporter result in an attenuation of HIV-1 Tat-induced inhibition of dopamine transport. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. 2015 Mar; 10(1):122-35. doi: 10.1007/s11481-015-9583-3. [PMID: 25604666]
  • Jordy van Enkhuizen, Brook L Henry, Arpi Minassian, William Perry, Morgane Milienne-Petiot, Kerin K Higa, Mark A Geyer, Jared W Young. Reduced dopamine transporter functioning induces high-reward risk-preference consistent with bipolar disorder. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2014 Dec; 39(13):3112-22. doi: 10.1038/npp.2014.170. [PMID: 25005251]
  • Vincent D Costa, Valery L Tran, Janita Turchi, Bruno B Averbeck. Dopamine modulates novelty seeking behavior during decision making. Behavioral neuroscience. 2014 Oct; 128(5):556-66. doi: 10.1037/a0037128. [PMID: 24911320]
  • Jun Yun, Minsoo Han, Chiman Song, Seung Hoon Cheon, Kihang Choi, Hoh-Gyu Hahn. Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors. Bioorganic & medicinal chemistry letters. 2014 Aug; 24(15):3234-7. doi: 10.1016/j.bmcl.2014.06.026. [PMID: 24974340]
  • Jung-eun Park, Chiman Song, Keehyun Choi, Taebo Sim, Bongjin Moon, Eun Joo Roh. Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors. Bioorganic & medicinal chemistry letters. 2013 Oct; 23(20):5515-8. doi: 10.1016/j.bmcl.2013.08.062. [PMID: 24012181]
  • Idaira Oliva, Miriam Fernández, Eduardo D Martín. Dopamine release regulation by astrocytes during cerebral ischemia. Neurobiology of disease. 2013 Oct; 58(?):231-41. doi: 10.1016/j.nbd.2013.06.007. [PMID: 23800715]
  • Jordy van Enkhuizen, Mark A Geyer, Klaas Kooistra, Jared W Young. Chronic valproate attenuates some, but not all, facets of mania-like behaviour in mice. The international journal of neuropsychopharmacology. 2013 Jun; 16(5):1021-31. doi: 10.1017/s1461145712001198. [PMID: 23164454]
  • Soyon Ahn, Anthony G Phillips. Daily monitoring of dopamine efflux reveals a short-lasting occlusion of the dopamine agonist properties of d-amphetamine by dopamine transporter blockers GBR 12909 and methylphenidate. ACS chemical neuroscience. 2013 May; 4(5):817-24. doi: 10.1021/cn400040r. [PMID: 23586444]
  • Jordy van Enkhuizen, Mark A Geyer, Jared W Young. Differential effects of dopamine transporter inhibitors in the rodent Iowa gambling task: relevance to mania. Psychopharmacology. 2013 Feb; 225(3):661-74. doi: 10.1007/s00213-012-2854-2. [PMID: 22945515]
  • Katsura Takano, Nobuyuki Tanaka, Kenji Kawabe, Mitsuaki Moriyama, Yoichi Nakamura. Extracellular superoxide dismutase induced by dopamine in cultured astrocytes. Neurochemical research. 2013 Jan; 38(1):32-41. doi: 10.1007/s11064-012-0882-2. [PMID: 22983620]
  • Dmitry M Mebel, Jovi C Y Wong, Yifei J Dong, Stephanie L Borgland. Insulin in the ventral tegmental area reduces hedonic feeding and suppresses dopamine concentration via increased reuptake. The European journal of neuroscience. 2012 Aug; 36(3):2336-46. doi: 10.1111/j.1460-9568.2012.08168.x. [PMID: 22712725]
  • Hongwen Qiao, Lin Zhu, Brian P Lieberman, Zhihao Zha, Karl Plössl, Hank F Kung. Synthesis and evaluation of novel tropane derivatives as potential PET imaging agents for the dopamine transporter. Bioorganic & medicinal chemistry letters. 2012 Jul; 22(13):4303-6. doi: 10.1016/j.bmcl.2012.05.030. [PMID: 22658558]
  • Oleg Kovtun, Emily J Ross, Ian D Tomlinson, Sandra J Rosenthal. A flow cytometry-based dopamine transporter binding assay using antagonist-conjugated quantum dots. Chemical communications (Cambridge, England). 2012 Jun; 48(44):5428-30. doi: 10.1039/c2cc31951a. [PMID: 22543630]
  • Dhananjay Sakrikar, Michelle S Mazei-Robison, Marc A Mergy, Nathan W Richtand, Qiao Han, Peter J Hamilton, Erica Bowton, Aurelio Galli, Jeremy Veenstra-Vanderweele, Michael Gill, Randy D Blakely. Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2012 Apr; 32(16):5385-97. doi: 10.1523/jneurosci.6033-11.2012. [PMID: 22514303]
  • Shaine A Cararas, Sari Izenwasser, Dean Wade, Amy Housman, Abha Verma, Stacey A Lomenzo, Mark L Trudell. Further structure-activity relationship studies on 8-substituted-3-[2-(diarylmethoxyethylidenyl)]-8-azabicyclo[3.2.1]octane derivatives at monoamine transporters. Bioorganic & medicinal chemistry. 2011 Dec; 19(24):7551-8. doi: 10.1016/j.bmc.2011.10.028. [PMID: 22055716]
  • Ivan Cakulev, Antonio E Lacerda, Celeen M Khrestian, Kyungmoo Ryu, Arthur M Brown, Albert L Waldo. Oral vanoxerine prevents reinduction of atrial tachyarrhythmias: preliminary results. Journal of cardiovascular electrophysiology. 2011 Nov; 22(11):1266-73. doi: 10.1111/j.1540-8167.2011.02098.x. [PMID: 21615815]
  • Olof Eriksson, Bengt Långström, Ray Josephsson. Assessment of receptor occupancy-over-time of two dopamine transporter inhibitors by [(11)C]CIT and target controlled infusion. Upsala journal of medical sciences. 2011 May; 116(2):100-6. doi: 10.3109/03009734.2011.563878. [PMID: 21443419]
  • Theresa A Kopajtic, Yi Liu, Christopher K Surratt, David M Donovan, Amy H Newman, Jonathan L Katz. Dopamine transporter-dependent and -independent striatal binding of the benztropine analog JHW 007, a cocaine antagonist with low abuse liability. The Journal of pharmacology and experimental therapeutics. 2010 Dec; 335(3):703-14. doi: 10.1124/jpet.110.171629. [PMID: 20855444]
  • J Park, B J Aragona, B M Kile, R M Carelli, R M Wightman. In vivo voltammetric monitoring of catecholamine release in subterritories of the nucleus accumbens shell. Neuroscience. 2010 Aug; 169(1):132-42. doi: 10.1016/j.neuroscience.2010.04.076. [PMID: 20451589]
  • Jared W Young, Mark A Geyer. Action of modafinil--increased motivation via the dopamine transporter inhibition and D1 receptors?. Biological psychiatry. 2010 Apr; 67(8):784-7. doi: 10.1016/j.biopsych.2009.12.015. [PMID: 20132929]
  • Jocelien D A Olivier, Alexander R Cools, Peter M T Deen, Berend Olivier, Bart A Ellenbroek. Blockade of dopamine, but not noradrenaline, transporters produces hyperthermia in rats that lack serotonin transporters. European journal of pharmacology. 2010 Mar; 629(1-3):7-11. doi: 10.1016/j.ejphar.2009.11.049. [PMID: 20004658]
  • Antonio E Lacerda, Yuri A Kuryshev, Gan-Xin Yan, Albert L Waldo, Arthur M Brown. Vanoxerine: cellular mechanism of a new antiarrhythmic. Journal of cardiovascular electrophysiology. 2010 Mar; 21(3):301-10. doi: 10.1111/j.1540-8167.2009.01623.x. [PMID: 19817928]
  • Jared W Young, Andrew K L Goey, Arpi Minassian, William Perry, Martin P Paulus, Mark A Geyer. GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior. Psychopharmacology. 2010 Feb; 208(3):443-54. doi: 10.1007/s00213-009-1744-8. [PMID: 20020109]
  • Andrea Varrone, Carsten Steiger, Magnus Schou, Akihiro Takano, Sjoerd J Finnema, Denis Guilloteau, Balázs Gulyás, Christer Halldin. In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand. Synapse (New York, N.Y.). 2009 Oct; 63(10):871-80. doi: 10.1002/syn.20670. [PMID: 19562698]
  • Helga Stopper, Nicole Schupp, Gholamreza Fazeli, Barbara Dietel, Nina Queisser, Susanne Walitza, Manfred Gerlach. Genotoxicity of the neurotransmitter dopamine in vitro. Toxicology in vitro : an international journal published in association with BIBRA. 2009 Jun; 23(4):640-6. doi: 10.1016/j.tiv.2009.03.001. [PMID: 19285549]
  • Emanuele Seu, Andrew Lang, Ronald J Rivera, J David Jentsch. Inhibition of the norepinephrine transporter improves behavioral flexibility in rats and monkeys. Psychopharmacology. 2009 Jan; 202(1-3):505-19. doi: 10.1007/s00213-008-1250-4. [PMID: 18604598]
  • Meredith A Fox, Catherine L Jensen, Helen T French, Alison R Stein, Su-Jan Huang, Teresa J Tolliver, Dennis L Murphy. Neurochemical, behavioral, and physiological effects of pharmacologically enhanced serotonin levels in serotonin transporter (SERT)-deficient mice. Psychopharmacology. 2008 Dec; 201(2):203-18. doi: 10.1007/s00213-008-1268-7. [PMID: 18712364]
  • Vladimir Stepanov, Jaak Järv. Kinetic mechanism of dopamine transporter interaction with 1-(2-(bis-(4-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine (GBR 12909). Neurochemistry international. 2008 Dec; 53(6-8):370-3. doi: 10.1016/j.neuint.2008.09.005. [PMID: 18845198]
  • Michael Y Aksenov, Marina V Aksenova, Janelle M Silvers, Charles F Mactutus, Rosemarie M Booze. Different effects of selective dopamine uptake inhibitors, GBR 12909 and WIN 35428, on HIV-1 Tat toxicity in rat fetal midbrain neurons. Neurotoxicology. 2008 Nov; 29(6):971-7. doi: 10.1016/j.neuro.2008.06.003. [PMID: 18606182]
  • Kyle C Schmitt, Juan Zhen, Prashant Kharkar, Manoj Mishra, Nianhang Chen, Aloke K Dutta, Maarten E A Reith. Interaction of cocaine-, benztropine-, and GBR12909-like compounds with wild-type and mutant human dopamine transporters: molecular features that differentially determine antagonist-binding properties. Journal of neurochemistry. 2008 Nov; 107(4):928-40. doi: 10.1111/j.1471-4159.2008.05667.x. [PMID: 18786172]
  • Jianjing Cao, Theresa Kopajtic, Jonathan L Katz, Amy Hauck Newman. Dual DAT/sigma1 receptor ligands based on 3-(4-(3-(bis(4-fluorophenyl)amino)propyl)piperazin-1-yl)-1-phenylpropan-1-ol. Bioorganic & medicinal chemistry letters. 2008 Oct; 18(19):5238-41. doi: 10.1016/j.bmcl.2008.08.065. [PMID: 18774292]
  • Pavlos Pissios, Lauren Frank, Adam R Kennedy, Douglas R Porter, Francis E Marino, Fen-Fen Liu, Emmanuel N Pothos, Eleftheria Maratos-Flier. Dysregulation of the mesolimbic dopamine system and reward in MCH-/- mice. Biological psychiatry. 2008 Aug; 64(3):184-91. doi: 10.1016/j.biopsych.2007.12.011. [PMID: 18281019]
  • Ling-Wei Hsin, Li-Te Chang, Richard B Rothman, Christina M Dersch, Arthur E Jacobson, Kenner C Rice. Design and synthesis of 2- and 3-substituted-3-phenylpropyl analogs of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine: role of amino, fluoro, hydroxyl, methoxyl, methyl, methylene, and oxo substituents on affinity for the dopamine and serotonin transporters. Journal of medicinal chemistry. 2008 May; 51(9):2795-806. doi: 10.1021/jm701270n. [PMID: 18393401]
  • Iain J A Macdougall, Renate Griffith. Pharmacophore design and database searching for selective monoamine neurotransmitter transporter ligands. Journal of molecular graphics & modelling. 2008 Apr; 26(7):1113-24. doi: 10.1016/j.jmgm.2007.10.003. [PMID: 18023378]
  • Yasushi Kiyono, Taku Sugita, Masashi Ueda, Hidekazu Kawashima, Naoki Kanegawa, Yuji Kuge, Yasuhisa Fujibayashi, Hideo Saji. Evaluation of radioiodinated (2S,alphaS)-2-(alpha-(2-iodophenoxy)benzyl)morpholine as a radioligand for imaging of norepinephrine transporter in the heart. Nuclear medicine and biology. 2008 Feb; 35(2):213-8. doi: 10.1016/j.nucmedbio.2007.11.006. [PMID: 18312831]
  • Teija Koivula, Päivi Marjamäki, Merja Haaparanta, Veronica Fagerholm, Tove Grönroos, Tiina Lipponen, Outi Perhola, Jouko Vepsäläinen, Olof Solin. Ex vivo evaluation of N-(3-[18F]fluoropropyl)-2 beta-carbomethoxy-3 beta-(4-fluorophenyl)nortropane in rats. Nuclear medicine and biology. 2008 Feb; 35(2):177-83. doi: 10.1016/j.nucmedbio.2007.09.006. [PMID: 18312827]
  • Paulo H C Diniz, Janice H Silva, Marcus V Gomez, Cristina Guatimosim, Renato S Gomez. Halothane increases non-vesicular [(3)H]dopamine release from brain cortical slices. Cellular and molecular neurobiology. 2007 Sep; 27(6):757-70. doi: 10.1007/s10571-007-9162-0. [PMID: 17680357]
  • Georgianna G Gould, Bryan W Brooks, Alan Frazer. [(3)H] citalopram binding to serotonin transporter sites in minnow brains. Basic & clinical pharmacology & toxicology. 2007 Sep; 101(3):203-10. doi: 10.1111/j.1742-7843.2007.00100.x. [PMID: 17697042]
  • F Wuest, M Berndt, K Strobel, J van den Hoff, X Peng, J L Neumeyer, R Bergmann. Synthesis and radiopharmacological characterization of 2beta-carbo-2'-[18F]fluoroethoxy-3beta-(4-bromo-phenyl)tropane ([18F]MCL-322) as a PET radiotracer for imaging the dopamine transporter (DAT). Bioorganic & medicinal chemistry. 2007 Jul; 15(13):4511-9. doi: 10.1016/j.bmc.2007.04.019. [PMID: 17467995]
  • Alberto Ambesi-Impiombato, Fabio Panariello, Carmela Dell'aversano, Carmine Tomasetti, Giovanni Muscettola, Andrea de Bartolomeis. Differential expression of Homer 1 gene by acute and chronic administration of antipsychotics and dopamine transporter inhibitors in the rat forebrain. Synapse (New York, N.Y.). 2007 Jun; 61(6):429-39. doi: 10.1002/syn.20385. [PMID: 17372981]
  • Nobuyuki Maruoka, Tetsuhito Murata, Naoto Omata, Yasuhiro Takashima, Yasuhisa Fujibayashi, Yuji Wada. Biphasic mechanism of the toxicity induced by 1-methyl-4-phenylpyridinium ion (MPP+) as revealed by dynamic changes in glucose metabolism in rat brain slices. Neurotoxicology. 2007 May; 28(3):672-8. doi: 10.1016/j.neuro.2007.02.008. [PMID: 17391768]
  • Kathleen M Gilbert, Terrence L Boos, Christina M Dersch, Elisabeth Greiner, Arthur E Jacobson, David Lewis, Dorota Matecka, Thomas E Prisinzano, Ying Zhang, Richard B Rothman, Kenner C Rice, Carol A Venanzi. DAT/SERT selectivity of flexible GBR 12909 analogs modeled using 3D-QSAR methods. Bioorganic & medicinal chemistry. 2007 Jan; 15(2):1146-59. doi: 10.1016/j.bmc.2006.09.070. [PMID: 17127069]
  • A Storch, Y-I Hwang, G Bringmann, D Feineis, S Ott, R Brückner, J Schwarz. Cytotoxicity of chloral-derived beta-carbolines is not specific towards neuronal nor dopaminergic cells. Journal of neural transmission (Vienna, Austria : 1996). 2006 Dec; 113(12):1895-901. doi: 10.1007/s00702-006-0495-5. [PMID: 16868795]
  • Nagendra V Chemuturi, Jon E Haraldsson, Thomas Prisinzano, Maureen Donovan. Role of dopamine transporter (DAT) in dopamine transport across the nasal mucosa. Life sciences. 2006 Aug; 79(14):1391-8. doi: 10.1016/j.lfs.2006.04.021. [PMID: 16733058]
  • Terrence L Boos, Elisabeth Greiner, W Jason Calhoun, Thomas E Prisinzano, Barbara Nightingale, Christina M Dersch, Richard B Rothman, Arthur E Jacobson, Kenner C Rice. Structure-activity relationships of substituted N-benzyl piperidines in the GBR series: Synthesis of 4-(2-(bis(4-fluorophenyl)methoxy)ethyl)-1-(2-trifluoromethylbenzyl)piperidine, an allosteric modulator of the serotonin transporter. Bioorganic & medicinal chemistry. 2006 Jun; 14(11):3967-73. doi: 10.1016/j.bmc.2006.01.065. [PMID: 16563775]
  • Ezio Carboni, Alessandra Silvagni, Cinzia Vacca, Gaetano Di Chiara. Cumulative effect of norepinephrine and dopamine carrier blockade on extracellular dopamine increase in the nucleus accumbens shell, bed nucleus of stria terminalis and prefrontal cortex. Journal of neurochemistry. 2006 Jan; 96(2):473-81. doi: 10.1111/j.1471-4159.2005.03556.x. [PMID: 16336224]
  • Balachandra K Gorentla, Roxanne A Vaughan. Differential effects of dopamine and psychoactive drugs on dopamine transporter phosphorylation and regulation. Neuropharmacology. 2005 Nov; 49(6):759-68. doi: 10.1016/j.neuropharm.2005.08.011. [PMID: 16181646]
  • Barbara Nightingale, Christina M Dersch, Terrence L Boos, Elisabeth Greiner, William J Calhoun, Arthur E Jacobson, Kenner C Rice, Richard B Rothman. Studies of the biogenic amine transporters. XI. Identification of a 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR12909) analog that allosterically modulates the serotonin transporter. The Journal of pharmacology and experimental therapeutics. 2005 Aug; 314(2):906-15. doi: 10.1124/jpet.105.084376. [PMID: 15860577]
  • Tatyana D Sotnikova, Jean-Martin Beaulieu, Larry S Barak, William C Wetsel, Marc G Caron, Raul R Gainetdinov. Dopamine-independent locomotor actions of amphetamines in a novel acute mouse model of Parkinson disease. PLoS biology. 2005 Aug; 3(8):e271. doi: 10.1371/journal.pbio.0030271. [PMID: 16050778]
  • Maarten E A Reith, Lijuan C Wang, Aloke K Dutta. Pharmacological profile of radioligand binding to the norepinephrine transporter: instances of poor indication of functional activity. Journal of neuroscience methods. 2005 Apr; 143(1):87-94. doi: 10.1016/j.jneumeth.2004.09.015. [PMID: 15763140]
  • Julie Broadbent, Kathryn M Kampmueller, Sharon A Koonse. Role of dopamine in behavioral sensitization to ethanol in DBA/2J mice. Alcohol (Fayetteville, N.Y.). 2005 Feb; 35(2):137-48. doi: 10.1016/j.alcohol.2005.03.006. [PMID: 15963427]
  • Juan Zhen, Soumen Maiti, Nianhang Chen, Aloke K Dutta, Maarten E A Reith. Interaction between a hydroxypiperidine analogue of 4-(2-benzhydryloxy-ethyl)-1-(4-fluorobenzyl)piperidine and Aspartate 68 in the human dopamine transporter. European journal of pharmacology. 2004 Dec; 506(1):17-26. doi: 10.1016/j.ejphar.2004.10.028. [PMID: 15588620]
  • Sárka Manáková, Katja A Puttonen, Atso Raasmaja, Pekka T Männistö. The roles of dopamine transporter and Bcl-2 protein in the protection of CV1-P cells from 6-OHDA-induced toxicity. Toxicology letters. 2004 Dec; 154(1-2):117-23. doi: 10.1016/j.toxlet.2004.07.007. [PMID: 15475185]
  • Rohit Kolhatkar, Charles D Cook, Sujit K Ghorai, Jeffrey Deschamps, Patrick M Beardsley, Maarten E A Reith, Aloke K Dutta. Further structurally constrained analogues of cis-(6-benzhydrylpiperidin-3-yl)benzylamine with elucidation of bioactive conformation: discovery of 1,4-diazabicyclo[3.3.1]nonane derivatives and evaluation of their biological properties for the monoamine transporters. Journal of medicinal chemistry. 2004 Oct; 47(21):5101-13. doi: 10.1021/jm049796t. [PMID: 15456254]
  • Norihiro Harada, Hiroyuki Ohba, Dai Fukumoto, Takeharu Kakiuchi, Hideo Tsukada. Potential of [(18)F]beta-CFT-FE (2beta-carbomethoxy-3beta-(4-fluorophenyl)-8-(2-[(18)F]fluoroethyl)nortropane) as a dopamine transporter ligand: A PET study in the conscious monkey brain. Synapse (New York, N.Y.). 2004 Oct; 54(1):37-45. doi: 10.1002/syn.20059. [PMID: 15300883]
  • Hao-Wei Shen, Yoko Hagino, Hideaki Kobayashi, Keiko Shinohara-Tanaka, Kazutaka Ikeda, Hideko Yamamoto, Toshifumi Yamamoto, Klaus-Peter Lesch, Dennis L Murphy, F Scott Hall, George R Uhl, Ichiro Sora. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2004 Oct; 29(10):1790-9. doi: 10.1038/sj.npp.1300476. [PMID: 15226739]
  • Lesley J Bryan-Lluka, Marisa H Papacostas, Filip A Paczkowski, Janet C Wanstall. Nitric oxide donors inhibit 5-hydroxytryptamine (5-HT) uptake by the human 5-HT transporter (SERT). British journal of pharmacology. 2004 Sep; 143(1):63-70. doi: 10.1038/sj.bjp.0705904. [PMID: 15302679]
  • Jason M Williams, Jeffery D Steketee. Characterization of dopamine transport in crude synaptosomes prepared from rat medial prefrontal cortex. Journal of neuroscience methods. 2004 Aug; 137(2):161-5. doi: 10.1016/j.jneumeth.2004.02.022. [PMID: 15262056]
  • Yong Yang, Xing Liu, Jian-Hua Ding, Jing Sun, Yan Long, Fang Wang, Hong-Hong Yao, Gang Hu. Effects of iptakalim on rotenone-induced cytotoxicity and dopamine release from PC12 cells. Neuroscience letters. 2004 Aug; 366(1):53-7. doi: 10.1016/j.neulet.2004.05.009. [PMID: 15265589]
  • James K Rowlett, Donna M Platt, Roger D Spealman. Cocaine-like discriminative stimulus effects of heroin: modulation by selective monoamine transport inhibitors. The Journal of pharmacology and experimental therapeutics. 2004 Jul; 310(1):342-8. doi: 10.1124/jpet.104.065631. [PMID: 14985417]
  • Santosh S Kulkarni, Peter Grundt, Theresa Kopajtic, Jonathan L Katz, Amy Hauck Newman. Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation. Journal of medicinal chemistry. 2004 Jun; 47(13):3388-98. doi: 10.1021/jm030646c. [PMID: 15189035]
  • Alexander Storch, Yu-I Hwang, Debra A Gearhart, J Warren Beach, Edward J Neafsey, Michael A Collins, Johannes Schwarz. Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake. Journal of neurochemistry. 2004 May; 89(3):685-94. doi: 10.1111/j.1471-4159.2004.02397.x. [PMID: 15086525]
  • Nianhang Chen, Juan Zhen, Maarten E A Reith. Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine. Journal of neurochemistry. 2004 May; 89(4):853-64. doi: 10.1111/j.1471-4159.2004.02386.x. [PMID: 15140185]
  • Vincent Castagné, Michaël Rougemont, Michel Cuenod, Kim Q Do. Low brain glutathione and ascorbic acid associated with dopamine uptake inhibition during rat's development induce long-term cognitive deficit: relevance to schizophrenia. Neurobiology of disease. 2004 Feb; 15(1):93-105. doi: 10.1016/j.nbd.2003.09.005. [PMID: 14751774]
  • V Valentini, R Frau, G Di Chiara. Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine. Journal of neurochemistry. 2004 Feb; 88(4):917-27. doi: 10.1046/j.1471-4159.2003.02238.x. [PMID: 14756813]
  • V Castagné, M Cuénod, K Q Do. An animal model with relevance to schizophrenia: sex-dependent cognitive deficits in osteogenic disorder-Shionogi rats induced by glutathione synthesis and dopamine uptake inhibition during development. Neuroscience. 2004; 123(4):821-34. doi: 10.1016/j.neuroscience.2003.11.012. [PMID: 14751276]
  • Makoto Kimura, Tomoko Masuda, Koji Yamada, Masaki Mitani, Nobuo Kubota, Nobuyuki Kawakatsu, Kenichi Kishii, Masato Inazu, Yuji Kiuchi, Katsuji Oguchi, Takayuki Namiki. Novel diphenylalkyl piperazine derivatives with high affinities for the dopamine transporter. Bioorganic & medicinal chemistry. 2003 Sep; 11(18):3953-63. doi: 10.1016/s0968-0896(03)00428-0. [PMID: 12927856]
  • Rohit B Kolhatkar, Sujit K Ghorai, Clifford George, Maarten E A Reith, Aloke K Dutta. Interaction of cis-(6-benzhydrylpiperidin-3-yl)benzylamine analogues with monoamine transporters: structure-activity relationship study of structurally constrained 3,6-disubstituted piperidine analogues of (2,2-diphenylethyl)-[1-(4-fluorobenzyl)piperidin-4-ylmethyl]amine. Journal of medicinal chemistry. 2003 May; 46(11):2205-15. doi: 10.1021/jm020561w. [PMID: 12747792]
  • Elisabeth Greiner, Thomas Prisinzano, Edward M Johnson, Christina M Dersch, Jamila Marcus, John S Partilla, Richard B Rothman, Arthur E Jacobson, Kenner C Rice. Structure-activity relationship studies of highly selective inhibitors of the dopamine transporter: N-benzylpiperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine. Journal of medicinal chemistry. 2003 Apr; 46(8):1465-9. doi: 10.1021/jm020419v. [PMID: 12672246]
  • David Lewis, Ying Zhang, Thomas Prisinzano, Christina M Dersch, Richard B Rothman, Arthur E Jacobson, Kenner C Rice. Further exploration of 1-[2-[Bis-(4-fluorophenyl)methoxy]ethyl]piperazine (GBR 12909): role of N-aromatic, N-heteroaromatic, and 3-oxygenated N-phenylpropyl substituents on affinity for the dopamine and serotonin transporter. Bioorganic & medicinal chemistry letters. 2003 Apr; 13(7):1385-9. doi: 10.1016/s0960-894x(03)00108-2. [PMID: 12657288]
  • Ling-Wei Hsin, Thomas Prisinzano, Chavon R Wilkerson, Christina M Dersch, Robert Horel, Arthur E Jacobson, Richard B Rothman, Kenner C Rice. Synthesis and dopamine transporter affinity of chiral 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(2-hydroxypropyl)piperazines as potential cocaine abuse therapeutic agents. Bioorganic & medicinal chemistry letters. 2003 Feb; 13(3):553-6. doi: 10.1016/s0960-894x(02)00940-x. [PMID: 12565970]
  • Masami Nakai, Atsushi Mori, Akihito Watanabe, Yasuhide Mitsumoto. 1-methyl-4-phenylpyridinium (MPP+) decreases mitochondrial oxidation-reduction (REDOX) activity and membrane potential (Deltapsi(m)) in rat striatum. Experimental neurology. 2003 Jan; 179(1):103-10. doi: 10.1006/exnr.2002.8056. [PMID: 12504872]
  • Päivi Marjamäki, Jörg Zessin, Olli Eskola, Tove Grönroos, Merja Haaparanta, Jörgen Bergman, Pertti Lehikoinen, Sarita Forsback, Peter Brust, Jörg Steinbach, Olof Solin. S-[18F]fluoromethyl-(+)-McN5652, a PET tracer for the serotonin transporter: evaluation in rats. Synapse (New York, N.Y.). 2003 Jan; 47(1):45-53. doi: 10.1002/syn.10150. [PMID: 12422372]
  • Michaël Rougemont, Kim Quang Do, Vincent Castagné. New model of glutathione deficit during development: Effect on lipid peroxidation in the rat brain. Journal of neuroscience research. 2002 Dec; 70(6):774-83. doi: 10.1002/jnr.10439. [PMID: 12444599]
  • Netta Roz, Yehuda Mazur, Amiram Hirshfeld, Moshe Rehavi. Inhibition of vesicular uptake of monoamines by hyperforin. Life sciences. 2002 Sep; 71(19):2227-37. doi: 10.1016/s0024-3205(02)01995-1. [PMID: 12215370]
  • Thomas Prisinzano, Elisabeth Greiner, Edward M Johnson, Christina M Dersch, Jamila Marcus, John S Partilla, Richard B Rothman, Arthur E Jacobson, Kenner C Rice. Piperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909): high affinity ligands for the dopamine transporter. Journal of medicinal chemistry. 2002 Sep; 45(19):4371-4. doi: 10.1021/jm020264r. [PMID: 12213078]
  • Jorge Camarero, Veronica Sanchez, Esther O'Shea, A Richard Green, M Isabel Colado. Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4-methylenedioxymethamphetamine ('ecstasy')-induced dopamine release and free radical formation in the mouse striatum. Journal of neurochemistry. 2002 Jun; 81(5):961-72. doi: 10.1046/j.1471-4159.2002.00879.x. [PMID: 12065608]
  • Michael H Baumann, Jennifer M Phillips, Mario A Ayestas, Syed F Ali, Kenner C Rice, Richard B Rothman. Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence. Annals of the New York Academy of Sciences. 2002 Jun; 965(?):92-108. doi: 10.1111/j.1749-6632.2002.tb04154.x. [PMID: 12105088]
  • Pippa S Loupe, Jonna D Bredemeier, Stephen R Schroeder, Richard E Tessel. Dopamine re-uptake inhibitor GBR-12909 induction of aberrant behaviors in animal models of dopamine dysfunction. International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience. 2002 Jun; 20(3-5):323-33. doi: 10.1016/s0736-5748(02)00054-0. [PMID: 12175869]
  • M S Mazei, C P Pluto, B Kirkbride, E A Pehek. Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat. Brain research. 2002 May; 936(1-2):58-67. doi: 10.1016/s0006-8993(02)02542-8. [PMID: 11988230]
  • Taleen Hanania, Nancy R Zahniser. Locomotor activity induced by noncompetitive NMDA receptor antagonists versus dopamine transporter inhibitors: opposite strain differences in inbred long-sleep and short-sleep mice. Alcoholism, clinical and experimental research. 2002 Apr; 26(4):431-40. doi: 10.1111/j.1530-0277.2002.tb02558.x. [PMID: 11981117]
  • Jose A Morón, Alicia Brockington, Roy A Wise, Beatriz A Rocha, Bruce T Hope. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2002 Jan; 22(2):389-95. doi: 10.1523/jneurosci.22-02-00389.2002. [PMID: 11784783]
  • J Cao, S M Husbands, T Kopajtic, J L Katz, A H Newman. [3-cis-3,5-Dimethyl-(1-piperazinyl)alkyl]-bis-(4'-fluorophenyl)amine analogues as novel probes for the dopamine transporter. Bioorganic & medicinal chemistry letters. 2001 Dec; 11(24):3169-73. doi: 10.1016/s0960-894x(01)00662-x. [PMID: 11720867]
  • Y Zhang, D B Joseph, W D Bowen, J L Flippen-Anderson, C M Dersch, R B Rothman, A E Jacobson, K C Rice. Synthesis and biological evaluation of tropane-like 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909) analogues. Journal of medicinal chemistry. 2001 Nov; 44(23):3937-45. doi: 10.1021/jm0101592. [PMID: 11689080]
  • B M Prasad, S G Amara. The dopamine transporter in mesencephalic cultures is refractory to physiological changes in membrane voltage. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2001 Oct; 21(19):7561-7. doi: 10.1523/jneurosci.21-19-07561.2001. [PMID: 11567046]
  • R A González-Polo, A Mora, N Clemente, G Sabio, F Centeno, G Soler, J M Fuentes. Mechanisms of MPP(+) incorporation into cerebellar granule cells. Brain research bulletin. 2001 Sep; 56(2):119-23. doi: 10.1016/s0361-9230(01)00610-4. [PMID: 11704348]
  • S A Cherstniakova, D Bi, D R Fuller, J Z Mojsiak, J M Collins, L R Cantilena. Metabolism of vanoxerine, 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine, by human cytochrome P450 enzymes. Drug metabolism and disposition: the biological fate of chemicals. 2001 Sep; 29(9):1216-20. doi: . [PMID: 11502731]
  • M Huotari, M Passlin, H L Nordberg, M Forsberg, S Kotisaari, L Tuomisto, F Shintani, K F Tanaka, I Reenilä, K Laitinen, P T Männistö. Effect of intracerebral 6-nitronoradrenaline, an endogenous catechol-O-methyltransferase (COMT) inhibitor, on striatal dopamine metabolism in anaesthetised rats. Journal of neuroscience methods. 2001 Aug; 109(1):47-52. doi: 10.1016/s0165-0270(01)00400-9. [PMID: 11489299]